Aminoglycoside antibiotics for sepsis with low kidney function
Part of Infections clinical trials.
This study tests how well aminoglycoside antibiotics work in people with sepsis who also have low kidney function. It may help find the best way to treat serious infections in patients with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have sepsis or septic shock (a serious infection affecting your whole body).
- Your kidney function is low (GFR less than 40 ml/min).
- You have a bloodstream infection caused by Gram-negative bacteria, and your doctor has decided to use an aminoglycoside antibiotic.
- A family member or close relative must sign a consent form for you to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
This trial studies how much certain antibiotics (meropenem, linezolid, and daptomycin) are removed when you're on a special blood-filtering machine called continuous renal replacement therapy (CRRT) for severe kidney injury. The results could help doctors give the right dose of antibiotics to treat infections effectively.
This study looks at how a common antibiotic is removed by kidney dialysis in very ill patients. This may help doctors give the right amount to keep the infection under control.
This study tests whether giving certain fluids and a blood-pressure-raising medicine together early can help prevent kidney damage (acute kidney injury) in people with septic shock. If you are in intensive care with septic shock, this treatment might protect your kidneys.
This trial tests whether different blood pressure medicines protect kidney function better in people with septic shock (a severe infection that causes low blood pressure). It compares norepinephrine (the standard treatment) with other options to see which is best for the kidneys.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.